These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34279838)

  • 1. Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19).
    Hsue VB; Itamura K; Wu AW; Illing EA; Sokoloski KJ; Weaver BA; Anthony BP; Hughes N; Ting JY; Higgins TS
    Adv Exp Med Biol; 2021; 1327():169-189. PubMed ID: 34279838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal Antiviral Drug Delivery and Coronavirus Disease 2019 (COVID-19): A State of the Art Review.
    Higgins TS; Wu AW; Illing EA; Sokoloski KJ; Weaver BA; Anthony BP; Hughes N; Ting JY
    Otolaryngol Head Neck Surg; 2020 Oct; 163(4):682-694. PubMed ID: 32660339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of Topical Povidone-iodine to Decrease Viral Load of COViD-19.
    Benson KM; Mancini AA; Brodeur MR
    Sr Care Pharm; 2021 May; 36(5):238-241. PubMed ID: 33879284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
    Santos J; Brierley S; Gandhi MJ; Cohen MA; Moschella PC; Declan ABL
    Viruses; 2020 Jun; 12(7):. PubMed ID: 32629804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Umifenovir and coronavirus infections: a review of research results and clinical practice].
    Leneva IA; Pshenichnaya NY; Bulgakova VA
    Ter Arkh; 2020 Dec; 92(11):91-97. PubMed ID: 33720612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Coronavirus Pandemic: What Does the Evidence Show?
    Paudel S; Dangal G; Chalise A; Bhandari TR; Dangal O
    J Nepal Health Res Counc; 2020 Apr; 18(1):1-9. PubMed ID: 32335585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19).
    Baggio S; L'Huillier AG; Yerly S; Bellon M; Wagner N; Rohr M; Huttner A; Blanchard-Rohner G; Loevy N; Kaiser L; Jacquerioz F; Eckerle I
    Clin Infect Dis; 2021 Jul; 73(1):148-150. PubMed ID: 32761228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: Topical agents and therapeutic prevention of nasal viral acquisition.
    Abdelhadi S; Ruszczak Z; Schwartz RA
    Dermatol Ther; 2021 Jan; 34(1):e14454. PubMed ID: 33107144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-based failure of a detergent virucidal for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) nasal infections: A preclinical study and randomized controlled trial.
    Esther CR; Kimura KS; Mikami Y; Edwards CE; Das SR; Freeman MH; Strickland BA; Brown HM; Wessinger BC; Gupta VC; Von Wahlde K; Sheng Q; Huang LC; Bacon DR; Kimple AJ; Ceppe AS; Kato T; Pickles RJ; Randell SH; Baric RS; Turner JH; Boucher RC
    Int Forum Allergy Rhinol; 2022 Sep; 12(9):1137-1147. PubMed ID: 35040594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: Pharmacology and kinetics of viral clearance.
    Farina N; Ramirez GA; De Lorenzo R; Di Filippo L; Conte C; Ciceri F; Manfredi AA; Rovere-Querini P
    Pharmacol Res; 2020 Nov; 161():105114. PubMed ID: 32758635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of antiviral activity of darunavir against SARS-CoV-2.
    De Meyer S; Bojkova D; Cinatl J; Van Damme E; Buyck C; Van Loock M; Woodfall B; Ciesek S
    Int J Infect Dis; 2020 Aug; 97():7-10. PubMed ID: 32479865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in understanding COVID-19: insights from the omics approach.
    Lin B; Liu J; Liu Y; Qin X
    Crit Rev Clin Lab Sci; 2021 Jun; 58(4):242-252. PubMed ID: 33375876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Derived Nasal Spray; A Proposed Approach for COVID-19 Disease Control.
    Hoseini-Tavassol Z; Ejtahed HS; Soroush AR; Sajjadpour Z; Hasani-Ranjbar S; Larijani B
    Infect Disord Drug Targets; 2021; 21(8):e160921191568. PubMed ID: 33602078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects.
    Liu CH; Lu CH; Wong SH; Lin LT
    Front Immunol; 2020; 11():616595. PubMed ID: 33613542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients.
    Huang YH; Huang JT
    J Med Virol; 2021 Jul; 93(7):4370-4373. PubMed ID: 33755218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.